Literature DB >> 12543774

Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells.

Margaret E Ginn-Pease1, Charis Eng.   

Abstract

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a tumor suppressor that causes cell cycle arrest. Lack of a nuclear locator sequence and a function in the cytosolic phosphatidylinositol 3'-kinase/Akt pathway diverted its study from the nucleus. However, immunohistochemistry revealed PTEN in the nucleus of normal cells and decreased nuclear PTEN in neoplastic tissues. Using protein expression analysis and fluoroscopic localization of green fluorescence protein-tagged PTEN, we examined nuclear PTEN in MCF-7 cells. We demonstrate that PTEN enters the nucleus and that nuclear PTEN varies throughout the cell cycle. Higher nuclear PTEN levels were associated with G0-G1 phase, and lower nuclear PTEN levels were associated with S phase. We postulate that nuclear PTEN activity might directly regulate the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543774

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Authors:  Anabel Gil; Amparo Andrés-Pons; Elena Fernández; Miguel Valiente; Josema Torres; Javier Cervera; Rafael Pulido
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

2.  FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus.

Authors:  Jian-Sheng Wang; Jing-Sen Shi; Yi-Zhuang Xu; Xiao-Yi Duan; Li Zhang; Jing Wang; Li-Ming Yang; Shi-Fu Weng; Jin-Guang Wu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.

Authors:  Cheng Zhang; Lucio Comai; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes.

Authors:  Mary K Leonard; Natasha T Hill; Ethan D Grant; Madhavi P Kadakia
Journal:  Arch Dermatol Res       Date:  2013-04-16       Impact factor: 3.017

5.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.

Authors:  Fatemeh Fouladkou; Tamara Landry; Hiroshi Kawabe; Antje Neeb; Chen Lu; Nils Brose; Vuk Stambolic; Daniela Rotin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

Review 6.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

7.  Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.

Authors:  Yu Wang; Todd Romigh; Xin He; Mohammed S Orloff; Robert H Silverman; Warren D Heston; Charis Eng
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

8.  PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.

Authors:  Chun-Ju Chang; David J Mulholland; Bahram Valamehr; Sherly Mosessian; William R Sellers; Hong Wu
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

9.  Nuclear PTEN levels and G2 progression in melanoma cells.

Authors:  Abraham I Jacob; Todd Romigh; Kristin A Waite; Charis Eng
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

10.  Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.

Authors:  Glenn P Lobo; Kristin A Waite; Sarah M Planchon; Todd Romigh; Najah T Nassif; Charis Eng
Journal:  Hum Mol Genet       Date:  2009-05-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.